Bank of New York Mellon’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.3M | Buy |
775,328
+32,777
| +4% | +$2.79M | 0.01% | 940 |
|
|
2026
Q1 | $64M | Sell |
742,551
-10,681
| -1% | -$959K | 0.01% | 852 |
|
|
2025
Q4 | $65.8M | Sell |
753,232
-4,297
| -0.6% | -$326K | 0.01% | 849 |
|
|
2025
Q3 | $43.4M | Sell |
757,529
-380,081
| -33% | -$21.9M | 0.01% | 1113 |
|
|
2025
Q2 | $67.1M | Sell |
1,137,610
-26,224
| -2% | -$1.69M | 0.01% | 812 |
|
|
2025
Q1 | $85.2M | Sell |
1,163,834
-189,797
| -14% | -$15.7M | 0.02% | 690 |
|
|
2024
Q4 | $112M | Sell |
1,353,631
-1,007,423
| -43% | -$79.5M | 0.02% | 594 |
|
|
2024
Q3 | $169M | Sell |
2,361,054
-252,570
| -10% | -$17.8M | 0.03% | 432 |
|
|
2024
Q2 | $179M | Sell |
2,613,624
-403,078
| -13% | -$24.1M | 0.03% | 403 |
|
|
2024
Q1 | $162M | Buy |
3,016,702
+110,912
| +4% | +$5.96M | 0.03% | 454 |
|
|
2023
Q4 | $155M | Buy |
2,905,790
+499,108
| +21% | +$24.3M | 0.03% | 460 |
|
|
2023
Q3 | $119M | Buy |
2,406,682
+1,069,419
| +80% | +$59.8M | 0.03% | 548 |
|
|
2023
Q2 | $79.6M | Buy |
1,337,263
+93,212
| +7% | +$5.31M | 0.02% | 748 |
|
|
2023
Q1 | $70.5M | Buy |
1,244,051
+436,652
| +54% | +$28M | 0.02% | 800 |
|
|
2022
Q4 | $60M | Sell |
807,399
-7,630
| -0.9% | -$520K | 0.01% | 884 |
|
|
2022
Q3 | $48.6M | Sell |
815,029
-24,027
| -3% | -$1.45M | 0.01% | 973 |
|
|
2022
Q2 | $47.1M | Buy |
839,056
+34,391
| +4% | +$2.26M | 0.01% | 1028 |
|
|
2022
Q1 | $59.4M | Sell |
804,665
-737
| -0.1% | -$51.2K | 0.01% | 989 |
|
|
2021
Q4 | $58.2M | Sell |
805,402
-24,220
| -3% | -$1.76M | 0.01% | 1045 |
|
|
2021
Q3 | $63.6M | Buy |
829,622
+13,183
| +2% | +$1.06M | 0.01% | 979 |
|
|
2021
Q2 | $63.3M | Buy |
816,439
+9,129
| +1% | +$649K | 0.01% | 984 |
|
|
2021
Q1 | $49.8M | Sell |
807,310
-11,784
| -1% | -$746K | 0.01% | 1118 |
|
|
2020
Q4 | $53.4M | Buy |
819,094
+15,101
| +2% | +$868K | 0.01% | 1014 |
|
|
2020
Q3 | $39.8M | Sell |
803,993
-51,325
| -6% | -$2.65M | 0.01% | 1045 |
|
|
2020
Q2 | $40.8M | Sell |
855,318
-53,043
| -6% | -$2.56M | 0.01% | 1007 |
|
|
2020
Q1 | $38.6M | Sell |
908,361
-205,658
| -18% | -$10.2M | 0.01% | 895 |
|
|
2019
Q4 | $65.6M | Sell |
1,114,019
-4,241
| -0.4% | -$230K | 0.02% | 821 |
|
|
2019
Q3 | $57.2M | Sell |
1,118,260
-52,523
| -4% | -$2.5M | 0.02% | 873 |
|
|
2019
Q2 | $49.5M | Sell |
1,170,783
-13,505
| -1% | -$586K | 0.01% | 982 |
|
|
2019
Q1 | $58.5M | Sell |
1,184,288
-296,721
| -20% | -$13.4M | 0.02% | 862 |
|
|
2018
Q4 | $64.1M | Sell |
1,481,009
-116,413
| -7% | -$5.81M | 0.02% | 744 |
|
|
2018
Q3 | $90.7M | Sell |
1,597,422
-30,805
| -2% | -$1.62M | 0.02% | 666 |
|
|
2018
Q2 | $82.2M | Sell |
1,628,227
-11,722
| -0.7% | -$611K | 0.02% | 706 |
|
|
2018
Q1 | $81.7M | Sell |
1,639,949
-215,786
| -12% | -$10.1M | 0.02% | 700 |
|
|
2017
Q4 | $76.3M | Sell |
1,855,735
-518,290
| -22% | -$18.1M | 0.02% | 764 |
|
|
2017
Q3 | $70.6M | Sell |
2,374,025
-248,942
| -9% | -$7.6M | 0.02% | 775 |
|
|
2017
Q2 | $87M | Sell |
2,622,967
-6,348
| -0.2% | -$199K | 0.02% | 649 |
|
|
2017
Q1 | $77.9M | Buy |
2,629,315
+58,811
| +2% | +$1.61M | 0.02% | 715 |
|
|
2016
Q4 | $63.8M | Buy |
2,570,504
+226,187
| +10% | +$5.14M | 0.02% | 781 |
|
|
2016
Q3 | $52.9M | Sell |
2,344,317
-193,914
| -8% | -$4.56M | 0.02% | 840 |
|
|
2016
Q2 | $60.5M | Buy |
2,538,231
+430,229
| +20% | +$10.3M | 0.02% | 748 |
|
|
2016
Q1 | $50.1M | Buy |
2,108,002
+40,210
| +2% | +$983K | 0.02% | 860 |
|
|
2015
Q4 | $57.5M | Sell |
2,067,792
-141,922
| -6% | -$3.56M | 0.02% | 775 |
|
|
2015
Q3 | $45.7M | Sell |
2,209,714
-54,487
| -2% | -$1.38M | 0.01% | 897 |
|
|
2015
Q2 | $58.1M | Buy |
2,264,201
+129,839
| +6% | +$3.29M | 0.02% | 826 |
|
|
2015
Q1 | $53.9M | Sell |
2,134,362
-231,543
| -10% | -$5.64M | 0.01% | 864 |
|
|
2014
Q4 | $56.2M | Buy |
2,365,905
+742,548
| +46% | +$16.4M | 0.01% | 824 |
|
|
2014
Q3 | $31.9M | Buy |
1,623,357
+467,545
| +40% | +$9.62M | 0.01% | 1128 |
|
|
2014
Q2 | $27.6M | Sell |
1,155,812
-668,651
| -37% | -$16.1M | 0.01% | 1248 |
|
|
2014
Q1 | $48.5M | Sell |
1,824,463
-70,628
| -4% | -$1.68M | 0.01% | 918 |
|
|
2013
Q4 | $38.2M | Buy |
1,895,091
+344,145
| +22% | +$6.39M | 0.01% | 1038 |
|
|
2013
Q3 | $27.1M | Buy |
1,550,946
+816,828
| +111% | +$14.1M | 0.01% | 1205 |
|
|
2013
Q2 | $12.4M | Buy |
+734,118
| New | +$11.3M | ﹤0.01% | 1656 |
|
Other funds holding GMED
BTW
GCM
AP
SIMG
Bank of New York Mellon's GMED Position: Q2 2026 in Review
Bank of New York Mellon increased its Globus Medical (GMED) stake by 4.4% in Q2 2026, buying an estimated $2.79M and bringing the position to 775,328 shares worth $61.3M. The position accounts for 0.01% of the portfolio, ranked #940.
Bank of New York Mellon first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. The position peaked at $179M in Q2 2024. 367 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Bank of New York Mellon held 775,328 shares of Globus Medical worth $61.3M as of Q2 2026.
- Bank of New York Mellon bought 32,777 Globus Medical shares in Q2 2026, an estimated $2.79M.
- Globus Medical made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #940 holding.
- Bank of New York Mellon first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Globus Medical position peaked at $179M in Q2 2024.
- 367 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.